Faculty Opinions recommendation of SOCS1/JAB is a negative regulator of LPS-induced macrophage activation.

Author(s):  
David Underhill
Nature ◽  
10.1038/34178 ◽  
1998 ◽  
Vol 391 (6662) ◽  
pp. 79-82 ◽  
Author(s):  
Mercedes Ricote ◽  
Andrew C. Li ◽  
Timothy M. Willson ◽  
Carolyn J. Kelly ◽  
Christopher K. Glass

2016 ◽  
Vol 196 (8) ◽  
pp. 3421-3428 ◽  
Author(s):  
Yang Xiang ◽  
Fiona Eyers ◽  
Cristan Herbert ◽  
Hock L. Tay ◽  
Paul S. Foster ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Susana López-López ◽  
María José Romero de Ávila ◽  
Natalia Carolina Hernández de León ◽  
Francisco Ruiz-Marcos ◽  
Victoriano Baladrón ◽  
...  

NOTCH4 is a member of the NOTCH family of receptors whose expression is intensively induced in macrophages after their activation by Toll-like receptors (TLR) and/or interferon-γ (IFN-γ). In this work, we show that this receptor acts as a negative regulator of macrophage activation by diminishing the expression of proinflammatory cytokines, such as IL-6 and IL-12, and costimulatory proteins, such as CD80 and CD86. We have observed that NOTCH4 inhibits IFN-γ signaling by interfering with STAT1-dependent transcription. Our results show that NOTCH4 reprograms the macrophage response to IFN-γ by favoring STAT3 versus STAT1 phosphorylation without affecting their expression levels. This lower activation of STAT1 results in diminished transcriptional activity and expression of STAT1-dependent genes, including IRF1, SOCS1 and CXCL10. In macrophages, NOTCH4 inhibits the canonical NOTCH signaling pathway induced by LPS; however, it can reverse the inhibition exerted by IFN-γ on NOTCH signaling, favoring the expression of NOTCH-target genes, such as Hes1. Indeed, HES1 seems to mediate, at least in part, the enhancement of STAT3 activation by NOTCH4. NOTCH4 also affects TLR signaling by interfering with NF-κB transcriptional activity. This effect could be mediated by the diminished activation of STAT1. These results provide new insights into the mechanisms by which NOTCH, TLR and IFN-γ signal pathways are integrated to modulate macrophage-specific effector functions and reveal NOTCH4 acting as a new regulatory element in the control of macrophage activation that could be used as a target for the treatment of pathologies caused by an excess of inflammation.


2020 ◽  
Vol 21 (10) ◽  
pp. 3508
Author(s):  
Eveline A.C. Goossens ◽  
Margreet R. de Vries ◽  
J. Wouter Jukema ◽  
Paul H.A. Quax ◽  
A. Yaël Nossent

Myostatin is a negative regulator of muscle cell growth and proliferation. Furthermore, myostatin directly affects the expression of 14q32 microRNAs by binding the 14q32 locus. Direct inhibition of 14q32 microRNA miR-495-3p decreased postinterventional restenosis via inhibition of both vascular smooth muscle cell (VSMC) proliferation and local inflammation. Here, we aimed to investigate the effects of myostatin in a mouse model for postinterventional restenosis. In VSMCs in vitro, myostatin led to the dose-specific downregulation of 14q32 microRNAs miR-433-3p, miR-494-3p, and miR-495-3p. VSMC proliferation was inhibited, where cell migration and viability remained unaffected. In a murine postinterventional restenosis model, myostatin infusion did not decrease restenosis, neointimal area, or lumen stenosis. Myostatin inhibited expression of both proliferation marker PCNA and of 14q32 microRNAs miR-433-3p, miR-494-3p, and miR-495-3p dose-specifically in cuffed femoral arteries. However, 14q32 microRNA expression remained unaffected in macrophages and macrophage activation as well as macrophage influx into lesions were not decreased. In conclusion, myostatin did not affect postinterventional restenosis. Although myostatin inhibits 14q32 microRNA expression and proliferation in VSMCs, myostatin had no effect on macrophage activation and infiltration. Our findings underline that restenosis is driven by both VSMC proliferation and local inflammation. Targeting only one of these components is insufficient to prevent restenosis.


2012 ◽  
Vol 10 (S1) ◽  
Author(s):  
Scott Canna ◽  
Katharine Slade ◽  
Michele Paessler ◽  
Portia Kreiger ◽  
Sheila Rao ◽  
...  

Author(s):  
Andreas Weigert ◽  
Andreas von Knethen ◽  
Dominique Thomas ◽  
Isabel Faria ◽  
Dmitry Namgaladze ◽  
...  

2021 ◽  
Vol 7 (18) ◽  
pp. eabd4742
Author(s):  
Jiyu Tong ◽  
Xuefei Wang ◽  
Yongbo Liu ◽  
Xingxing Ren ◽  
Anmin Wang ◽  
...  

m6A RNA modification is implicated in multiple cellular responses. However, its function in the innate immune cells is poorly understood. Here, we identified major m6A “writers” as the top candidate genes regulating macrophage activation by LPS in an RNA binding protein focused CRISPR screening. We have confirmed that Mettl3-deficient macrophages exhibited reduced TNF-α production upon LPS stimulation in vitro. Consistently, Mettl3flox/flox;Lyzm-Cre mice displayed increased susceptibility to bacterial infection and showed faster tumor growth. Mechanistically, the transcripts of the Irakm gene encoding a negative regulator of TLR4 signaling were highly decorated by m6A modification. METTL3 deficiency led to the loss of m6A modification on Irakm mRNA and slowed down its degradation, resulting in a higher level of IRAKM, which ultimately suppressed TLR signaling–mediated macrophage activation. Our findings demonstrate a previously unknown role for METTL3-mediated m6A modification in innate immune responses and implicate the m6A machinery as a potential cancer immunotherapy target.


Sign in / Sign up

Export Citation Format

Share Document